 Biocon Academy, a centre of excellence for advanced learning in applied biosciences and a CSR initiative of Biocon Group, an innovation-led global biopharmaceuticals company, has announced the launch of its 8th programme, and the first in the area of artificial intelligence. The Syngene IBAB Certificate Programme in Artificial Intelligence in Life Sciences (SAILS) has been developed in partnership with Syngene, a Biocon Group Company and the Institute of Bioinformatics and Applied Biotechnology (IBAB). This first-of-its-kind Certificate Program reflects Biocon Academy’s commitment to advancing high-quality, industry-relevant education in India’s biotechnology sector.
SAILS is designed as a future-oriented, industry-aligned certification that integrates core disciplines such as artificial intelligence (AI), data science, and life sciences, to develop talent equipped for cutting-edge research, innovation, and discovery. Admissions are open for the programme, and the first batch of classes will commence in Q1 FY2027.
The 16-week certificate programme is designed to equip graduates and postgraduates in computer science, information technology, pharmacy, and life sciences disciplines (biotechnology, microbiology, and biochemistry), with cutting-edge knowledge. The programme provides a strong foundation in applying AI to solve complex problems in the Life Sciences industry, with an emphasis on real-life problem-solving skills. The launch of the SAILS programme highlights Biocon Group’s broader vision of advancing scientific excellence and enabling the next generation of biotech professionals.
Bindu Ajit, Programme Dean, Biocon Academy, said “The integration of Artificial Intelligence with biology is not just an emerging trend, it is rapidly becoming the backbone of modern scientific innovation. The SAILS programme has been designed with this vision in mind: to empower learners with the interdisciplinary expertise needed to excel in AI driven drug discovery, genomics, and precision medicine.”
With the rapid adoption of AI-driven approaches in areas like drug development, diagnostics, and molecular research, there is a growing need for skilled talent that can bridge computational sciences and biology. The SAILS programme aims to address this industry gap by equipping learners with practical, interdisciplinary skills and hands-on exposure to emerging technologies, said the communication note.
Prof. D. Sundar, director IBAB and Biocon Chair, said, " The convergence of AI and life sciences is opening unprecedented opportunities, and the SAILS program stands at the forefront of this transformation. Through this collaboration with Biocon Academy and Syngene, we aim to nurture professionals who can bridge computational intelligence with biological insight—individuals capable of solving complex scientific challenges using data, models, and innovation."
|